SYDNEY, 18, FEB 2026 – The landscape of medical device safety in Australia has officially shifted. On March 21, 2026, the Therapeutic Goods Administration (TGA) moved from a voluntary reporting culture for hospitals to a strict, mandatory framework. This regulatory evolution, driven by the findings of the 2017-18 Senate Inquiry into transvaginal mesh implants, aims to eliminate the “blind spots” that previously delayed the detection of long-term safety issues. The TGA Adverse Event Reporting system is central to this shift, ensuring that safety signals are identified more promptly.
For medical device manufacturers and sponsors, this is not just a hospital-level administrative change. It represents a fundamental shift in how the TGA Therapeutic Goods Administration identifies safety signals, directly impacting your Quality Management Systems (QMS), risk assessments, and market standing. Compliance with the Therapeutic Goods Act 1989 will be more critical than ever as the TGA strengthens its oversight in detecting potential risks to patients.
WHAT IS THE NEW TGA THERAPEUTIC GOODS ADMINISTRATION REQUIREMENT?
The new regulations mandate that all Australian public, private, and day hospital facilities report medical device adverse events directly to the TGA Therapeutic Goods Administration (TGA). Previously, reporting by healthcare facilities was voluntary, resulting in a system where over 92% of reports came from industry and less than 8% came from the clinical front lines.
Starting today, hospitals must use the new Adverse Signal Detection and Event Reporting (ASDER) system to report incidents. Unlike the existing voluntary IRIS system, ASDER is designed for high-volume signal detection and trend analysis, aligning with the TGA Adverse Event Reporting requirements. This change will directly impact your Quality Management Systems (QMS), as the TGA’s focus on adverse event reporting intensifies under the Therapeutic Goods Act 1989.
THE 2026 TIMELINE: WHERE WE ARE TODAY
The transition is being managed through a phased approach to allow facilities to build the necessary IT infrastructure:
- Stage 1 (Started March 21, 2026): Mandatory reporting is now live for adverse events resulting in death or serious deterioration involving high-risk devices (Class III and Class 4 IVDs).
- Stage 2 (Starts April 1, 2028): Requirements expand to medium-risk devices (Class IIa, IIb, and Class 3 IVDs) and include “near miss” events.
- Stage 3 (Starts April 1, 2030): Full implementation, including all previously mentioned classes and the provision of treatment for serious injury.
WHY THIS MATTERS FOR MANUFACTURERS
While the obligation to report falls on the healthcare facility, the consequences of those reports fall squarely on the manufacturer. Here is why this matters now:
- Increased TGA Scrutiny: The TGA will use ASDER data to identify trends across Australia. If a “signal” is detected for your device, the TGA may initiate a post-market review, regardless of whether you have received a direct complaint.
- Data Divergence: There are now two streams of data IRIS (industry/voluntary) and ASDER (mandatory hospital). Discrepancies between what you report and what hospitals report could flag a failure in your internal complaint-handling processes.
- Signal Prioritization: Data from the hospital stream will help the TGA prioritize investigations into reports received from sponsors.
WHAT MANUFACTURERS NEED TO DO NOW
To stay compliant and protect your market access, manufacturers and sponsors should implement the following changes:
1. Update Post-Market Surveillance (PMS) Plans
Your PMS system must be proactive. You should expect more frequent requests for information from the TGA and ensure your team is prepared to investigate signals derived from the ASDER database, even if they aren’t provided with individual patient details.
2. Improve Device Traceability
Hospitals are now required to provide device descriptions and manufacturer names. Ensure your Unique Device Identifier (UDI) and model numbers are clearly visible and accessible to hospital staff to ensure accurate reporting.
3. Review QMS Reporting Windows
Hospitals must report deaths and serious deteriorations within 10 days. Manufacturers should verify that their internal notification systems are fast enough to keep pace with the TGA’s now-accelerated awareness of hospital-side incidents.
COMPLIANCE RISKS AND CONSEQUENCES FOR TGA ADVERSE EVENT REPORTING
The TGA has made it clear that this is a high-stakes transition. For hospitals, the penalty for non-compliance is 30 penalty units per incident.
For manufacturers, the risks are broader:
- Regulatory Action: Signals detected via mandatory reporting can lead to product cancellations from the ARTG, mandatory label changes, or limitations on device use.
- Business Risk: Delayed awareness of a safety trend can result in significant legal and financial liability.
CONCLUSION
The commencement of Stage 1 marks the end of “passive” safety monitoring in Australia. Manufacturers who embrace this transparency by refining their signal detection and maintaining rigorous traceability through TGA Adverse Event Reporting will be better positioned to navigate this new regulatory environment.